MedPath

Haloperidol Decanoate

HALOPERIDOL DECANOATE 50 HALOPERIDOL DECANOATE 100 For IM Injection Only

Approved
Approval ID

9f0f42a8-5f7c-4be7-93ef-3ec225502cc6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 10, 2020

Manufacturers
FDA

Patriot Pharmaceuticals LLC

DUNS: 178220385

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Haloperidol Decanoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10147-0921
Application NumberNDA018701
Product Classification
M
Marketing Category
C73605
G
Generic Name
Haloperidol Decanoate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateDecember 10, 2020
FDA Product Classification

INGREDIENTS (3)

Haloperidol DecanoateActive
Quantity: 50 mg in 1 mL
Code: AC20PJ4101
Classification: ACTIM
sesame oilInactive
Code: QX10HYY4QV
Classification: IACT
benzyl alcoholInactive
Code: LKG8494WBH
Classification: IACT

Haloperidol Decanoate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code10147-0922
Application NumberNDA018701
Product Classification
M
Marketing Category
C73605
G
Generic Name
Haloperidol Decanoate
Product Specifications
Route of AdministrationINTRAMUSCULAR
Effective DateDecember 10, 2020
FDA Product Classification

INGREDIENTS (3)

Haloperidol DecanoateActive
Quantity: 100 mg in 1 mL
Code: AC20PJ4101
Classification: ACTIM
sesame oilInactive
Code: QX10HYY4QV
Classification: IACT
benzyl alcoholInactive
Code: LKG8494WBH
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Haloperidol Decanoate - FDA Drug Approval Details